<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Advisory Committee: Bone, Reproductive and Urologic Drugs Advisory Committee</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Advisory Committee: Bone, Reproductive and Urologic Drugs Advisory Committee</h1>
    <p class="timestamp">Published: 2014-04-11 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is amending the standing advisory committees' regulations to change the name and function of the Advisory Committee for Reproductive Health Drugs. This action is being taken to reflect changes made to the charter for this advisory committee.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2014-08151</p>
    <p><strong>Publication Date:</strong> 2014-04-11</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2014/04/11/2014-08151/advisory-committee-bone-reproductive-and-urologic-drugs-advisory-committee">https://www.federalregister.gov/documents/2014/04/11/2014-08151/advisory-committee-bone-reproductive-and-urologic-drugs-advisory-committee</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-08151</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
